HALO:NASDAQ
Halozyme Therapeutics, Inc.
$110.79
arrow_upward
+0.98%(+1.07) 1D
$110.79
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 7, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa HALO...
Buksan
$111.62
Mataas
$114.00
Mababa
$110.16
Mkt. cap
12.57B
Avg. na dami
2.23M
Dami
2.18M
P/E ratio
33.10
Mataas nang 52-wk
$116.84
Mababa nang 52-wk
$61.22
EPS
$3.35
Beta
0.88
Mga natitirang share
113.50M
Bilang ng mga empleyado
423
Buksan
$111.62
Mataas
$114.00
Mababa
$110.16
Mkt. cap
12.57B
Avg. na dami
2.23M
Dami
2.18M
P/E ratio
33.10
Mataas nang 52-wk
$116.84
Mababa nang 52-wk
$61.22
EPS
$3.35
Beta
0.88
Mga natitirang share
113.50M
Bilang ng mga empleyado
423
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Yahoo Finance
·
5 oras ang nakalipas
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
Barron's
·
7 oras ang nakalipas
Merck’s Keytruda Is Dealt a Legal Setback. It’s Good News for This Biotech Stock.
Euronext Markets: Real-time Stock Market Data | live
·
8 oras ang nakalipas
Halozyme wins court order to block Merck's injected Keytruda in select European markets
Investing.com Canada
·
11 oras ang nakalipas
Why is Halozyme Therapeutics stock climbing today? By Investing.com
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Tungkol sa Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Mga Empleyado423
Itinatag1998
HeadquartersSan Diego, California, Estados Unidos
Sektor-
Websitehalozyme.com